BIO-key Registers 1.24M Warrant Shares for Resale After Stockholder Vote Fails
BKYI is trading near its 52-week low of $1.607 (0.5% below the low).
Summary
BIO-key registered 1.24M shares for resale by Armistice Capital, but the filing reveals stockholders rejected the warrant exercise proposal and the vote has been adjourned to October 30.
Key Events · Financing and Capital Events · BKYI
-
Resale Registration Filed
S-1 registers 1,236,668 shares underlying warrants issued to Armistice Capital Master Fund in the August 10, 2026 inducement transaction.
-
Stockholder Vote Failed
The proposal to approve warrant exercise was NOT approved at the September 3 annual meeting; the meeting has been adjourned to October 30, 2026.
-
Potential Proceeds
If all warrants are exercised for cash at $4.06 per share, BIO-key would receive approximately $5.02 million in gross proceeds for working capital.
-
Exercise Price Above Market
The $4.06 exercise price is significantly above the current $1.60 stock price, making cash exercise unlikely without a substantial price increase.
Analysis · BKYI · Technology
BIO-key filed an S-1 to register the resale of 1,236,668 shares underlying warrants issued to Armistice Capital in the August 2026 inducement transaction. The filing reveals that stockholders did NOT approve the warrant exercise proposal at the September 3 annual meeting, and the meeting has been adjourned to October 30, 2026. If the warrants are exercised for cash at $4.06 per share, BIO-key would receive approximately $5.02 million in gross proceeds — capital the company needs given its going-concern warning. However, the warrants are currently unexercisable without stockholder approval, and the stock trades at $1.60, well below the $4.06 exercise price, making cash exercise unlikely in the near term.
How filings like this one have moved
In the 30 days to Oct 9, 2026, 28.2% of the 1631 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BKYI was trading at $1.60 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.4M. The 52-week trading range was $1.61 to $19.70. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.